ArticleFrontiers in pharmacology2021

A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of HOT-3010 to Adalimumab Among Healthy Chinese Male Subjects.

Hong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.